SLPI Antibody, FITC conjugated

說明書

中文名稱：

SLPI兔多克隆抗體, FITC偶聯
貨號：

CSB-PA07154C0Rb
規格：

￥880
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) SLPI Polyclonal antibody
Uniprot No.：

P03973
基因名：

SLPI
別名：

ALK 1 antibody; ALK1 antibody; ALP antibody; Antileukoprotease antibody; Antileukoproteinase 1 antibody; Antileukoproteinase antibody; Antileukoproteinase1 antibody; BLPI antibody; Human seminal protease inhibitor antibody; HUSI 1 antibody; HUSI antibody; HUSI I antibody; HUSI-1 antibody; MPI antibody; Mucus proteinase inhibitor antibody; Protease inhibitor WAP4 antibody; Secretory leukocyte peptidase inhibitor antibody; Secretory leukocyte protease inhibitor antibody; Seminal proteinase inhibitor antibody; SLPI antibody; SLPI_HUMAN antibody; WAP four disulfide core domain protein 4 antibody; WAP four-disulfide core domain protein 4 antibody; WAP4 antibody; WFDC4 antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Antileukoproteinase protein (26-132AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

FITC
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產品提供形式：

Liquid
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Acid-stable proteinase inhibitor with strong affinities for trypsin, chymotrypsin, elastase, and cathepsin G. Modulates the inflammatory and immune responses after bacterial infection, and after infection by the intracellular parasite L.major. Down-regulates responses to bacterial lipopolysaccharide (LPS). Plays a role in regulating the activation of NF-kappa-B and inflammatory responses. Has antimicrobial activity against mycobacteria, but not against salmonella. Contributes to normal resistance against infection by M.tuberculosis. Required for normal resistance to infection by L.major. Required for normal wound healing, probably by preventing tissue damage by limiting protease activity. Together with ELANE, required for normal differentiation and proliferation of bone marrow myeloid cells.
基因功能參考文獻：
1. Study indicate that SLPI seems to be one of the important immunomodulatory proteins that provide local immune response in cervical mucosa. PMID: 30180755
2. we investigated the biological effects of SLPI using Cell Counting Kit (CCK)-8, Annexin V/PI apoptosis assay and Caspase-Glo(R) 3/7 assay. The findings revealed that SLPI promoted apoptosis in the Leuk1 and WSU-HN4 cell lines. Mechanistic studies indicated that SLPI, at least in part, regulated cell apoptosis by inhibiting the expression of TNF receptor-associated factor 1 PMID: 29436667
3. Together, these data support the clinical evaluation of dual angiogenic inhibition of the ALK1 and VEGF pathways in patients with advanced renal cell carcinoma (RCC) . PMID: 28031424
4. the patients with systemic sclerosis had significantly increased serum levels of SLPI in comparison with the rheumatoid arthritis patients and the healthy controls PMID: 28606626
5. gene expression profiling study based on microarray data for the three cell types identified a number of candidates, including LCP1 and GLI, that could be key molecules in the mechanism of SLPI-induced cell migration PMID: 28637988
6. we show that SLPI acts as a key mediator in regulating the function of hepatic myeloid cells, to promote resolution responses through induction of MerTK expression within the resident macrophage population. PMID: 28450389
7. these data demonstrate increased anti-inflammatory activity of the SLPI-A16G protein compared with SLPI-WT in a murine model of pulmonary Pseudomonas infection PMID: 26376365
8. we demonstrated that the oncogenic effect of SLPI may be due to protection of growth factor progranulin from enzymatic cleavage or suppression of castration-resistant prostate cancer (CRPC)cell apoptosis independent of anti-protease activity of SLPI. These findings implicate SLPI as a potential biomarker of resistance to AR inhibition and therapeutic target for CRPC treatment PMID: 26876202
9. Secretory leukocyte protease inhibitor mediates invasiveness of oral carcinoma cells. PMID: 27238568
10. The results indicate that SERPINE2 and SLPI play a significant role in the development of papillary thyroid cancer and imply that the evaluation of serum concentrations of both anticoagulant molecules may be considered as additional marker for the differentiation of malignancies during the preoperative diagnosis of patients with thyroid gland tumors. PMID: 28255192
11. Bronchial epithelial cells have decreased SLPI expression in response to hypoxia. PMID: 25851169
12. Ongoing herpes simplex virus infection and resultant downregulation of local levels of SLPI may impart a greater susceptibility for keratinocytes to human papillomavirus type 16 infection through the host cell receptor annexin A2. PMID: 26555393
13. SLPI is an independent predictor for both OS and DSS and a relevant prognostic biomarker in OSCC. PMID: 24764155
14. The elevations in cervical elafin and SLPI expression in the women with preterm delivery might reflect the local response to the pathogen invasion into the cervix preceding preterm labor. PMID: 25559229
15. These results demonstrate that SLPI down-regulates pIgR expression through the NF-kappaB signaling pathway by inhibiting degradation of IkappaBbeta protein. PMID: 26239418
16. Abnormal over-expression of SLPI in pancreatic cancer cells may be associated with the development of disease through its roles in promoting cancer cell survival and proliferation as well as anti-apoptosis. PMID: 25319722
17. study identifies a distinct immune response in SA characterized by a dysregulated IFN-gamma/SLPI axis that affects lung function. PMID: 26121748
18. findings support a controlling role for SLPI in NET generation, which is of potential relevance to infectious and autoinflammatory diseases PMID: 25917460
19. We identify SLPI as a new player in acquisition of microbial hyporesponsiveness by buccal and intestinal epithelium in the first weeks after microbial colonisation. PMID: 25056659
20. Studies suggest that secretory leukocyte protease inhibitor (SLPI) as a mediator of systemic immune paresis in acute liver failure (ALF). PMID: 25041028
21. Report presence of SLPI in vaginal secretions and its regulation in response to vaginal microbiota and to the concentrations of antimicrobial and proinflammatory mediators. PMID: 24023032
22. Both mRNA and protein levels of SLPI were significantly higher in patients with biofilm associated chronic rhinosinusitis (CRS) than those with CRS and no biofilm and controls. PMID: 24121782
23. These results show that Mycobacterium tuberculosis-induced IFN-gamma down-modulated SLPI levels by signaling through the IFN-gammaR in healthy donors. PMID: 24606882
24. SLPI has antiprotease activity and antimicrobial activity against bacteria and fungi. SLPI is an important molecule in the functioning of the innate immune system. PMID: 16336202
25. findings demonstrate that SLPI plays an important role from the initial stages of lung carcinogenesis to the progression of lung cancer in an NF-kappaB-dependent manner PMID: 24282288
26. These results indicate that SLPI controls the proliferation, differentiation, and cell cycle of myeloid cells. PMID: 24352879
27. The aim of this study was to investigate the intracellular function of SLPI and the mechanism-based modulation of neutrophil function by this antiprotease. PMID: 24073410
28. Low SLPI expression is associated with papillomavirus infected head and neck squamous cell carcinomas. PMID: 23996702
29. SLPI is bactericidal for gonococci and is expressed by reproductive tract epithelial cells and thus is likely to play a role in the pathogenesis of gonococcal infection. PMID: 22537232
30. SLPI may contribute to psoriasis by enabling pDCs to sense extracellular DNA and produce IFN type I. PMID: 22786767
31. Circulating SLPI increases with progressive metabolic dysfunction and is related to metabolic and inflammatory parameters in men PMID: 21377455
32. confirmed that SLPI is significantly down-regulated in NPC tissues. In addition, based on our preliminary results, we propose that the reduction of SLPI in NPC cells is associated with the presence of the EBV genome and/or expression of EBV-encoded genes PMID: 22493362
33. decreased expression in female reproductive tract in postmenopausal women with hormonal treatment PMID: 21940052
34. Results show that SLPI promotes the metastasis of SNU638 gastric cancer cells by increasing MMP-2 and MMP-9 expression through Elk-1 signaling, indicating its role as a signaling molecule not a protease inhibitor. PMID: 21687932
35. SLPI may possess antitumorigenic activity by virtue of its ability to interfere with multiple requisite proteolytic steps underlying tumor cell invasion. PMID: 21641406
36. SLPI stimulates ovarian cancer invasion, modulated in part by its serine protease inhibitory activity attenuating MMP-9 release. PMID: 21676452
37. The results presented here clearly indicate the repression of SLPI, measurable on both, mRNA and protein levels in metastatic primary HNSCC as compared to non-metastatic HNSCC. PMID: 21503571
38. Constitutive expression of SLPI directly reduces the inflammatory response in the respiratory tract and improves lung function in an acute model of allergic asthma in SLPI transgenic and knockout mice. PMID: 21335488
39. these findings indicate upregulation of SLPI in response to LPS in nasal secretions and show anti-apoptotic effects of SLPI in primary human neutrophils suggesting a new role of SLPI during neutrophilic inflammation. PMID: 21077989
40. SLPI inhibited the expression of MMP-9 and IL-8 in normal human bronchial epithelial cells induced by cigarette smoke extract. PMID: 18953959
41. 17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor PMID: 20378727
42. Our observations are the first to implicate SPARC, SLPI, and NLRP2, a component of the innate immune system, in the pathogenesis of axial spondyloarthropathy PMID: 19900269
43. Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cells, and contribute to drug resistance. PMID: 20068074
44. Using transgenic mice over-expressing secretory leukocyte protease inhibitor, this study shows an early protective effect after spinal cord contusion injury. PMID: 20047904
45. Synthesized locally at mucosal sites. Efficiently inhibit target enzymes released into interstitium. Might be important in controlling excessive neutrophil elastase release in chronic obstructive pulmonary disease and cystic fibrosis. (review) PMID: 11667971
46. Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa. PMID: 11759111
47. possible role in the defence against ascending urinary tract infections; establishing a source of SLPI in renal tubuli cells. PMID: 11817677
48. Secretory leukocyte proteinase inhibitor and elafin are resistant to degradation by MMP-8. PMID: 11868825
49. results indicate that menstrual status (pre- vs. postmenopausal) influences the production of SLPI and bactericidal activity by uterine epithelial cells PMID: 12023766
50. mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes PMID: 12023969
顯示更多

收起更多
亞細胞定位：

Secreted.
組織特異性：

Detected in blood plasma. Detected in bone marrow myeloid cells. Detected in airway sputum. Detected in parotid gland secretions. Detected in seminal plasma (at protein level). Detected in uterus cervix.
數據庫鏈接：

HGNC: 11092

OMIM: 107285

KEGG: hsa:6590

STRING: 9606.ENSP00000342082

UniGene: Hs.517070

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human